Scholar Rock Holding SRRK
NASDAQ SRRK
$47.75 -1.38 (-2.81%)
At close: Sep 29, 2026 · 4:00 PM EDT

Scholar Rock Holding (SRRK) Total Current Liabilities (2017 - 2026)

Updated

Scholar Rock Holding (SRRK) posted Total Current Liabilities of $72.24 million for Q2 2026, up 43.2% from $50.44 million a year earlier and up 21.1% from the prior quarter.

Analysis

Scholar Rock Holding (SRRK) Total Current Liabilities (2017 - 2026) Analysis & Trends

At the end of FY2025, Scholar Rock Holding's Total Current Liabilities came in at $55.42 million, up 18.1% from FY2024.

  • Annual Total Current Liabilities shows a five-year compound annual growth rate of 5.4% (FY2020 to FY2025).
  • In prior years, Scholar Rock Holding's Total Current Liabilities was $46.94 million in FY2024 (+43.4%), $32.74 million in FY2023 (-10.0%), $36.39 million in FY2022 (-43.4%) and $64.3 million in FY2021 (+51.1%).
  • The Q2 2026 figure stands as the highest quarterly Total Current Liabilities in data going back to Q4 2017.
  • On a year-over-year basis, Total Current Liabilities has increased in each of the last ten quarters, with growth averaging 40.1% over the last eight quarters.
  • The strongest year-over-year quarter for Total Current Liabilities in the past five years was Q3 2021, with growth of 96.5%; the weakest was Q1 2022, with a decline of 52.3%.
  • According to Business Quant data, Total Current Liabilities for the three prior quarters was $59.64 million (Q1 2026), $55.42 million (Q4 2025) and $61.97 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 54.90 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 41.64 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -31.55 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.02 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 32.65 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 3.94 Bn
10 Scholar Rock Holding 5.97 Bn 5.97 Bn - 72.24 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 72.24 Mn
Mar 31, 2026 59.64 Mn
Dec 31, 2025 55.42 Mn
Sep 30, 2025 61.97 Mn
Jun 30, 2025 50.44 Mn
Mar 31, 2025 37.57 Mn
Dec 31, 2024 46.94 Mn
Sep 30, 2024 39.37 Mn
Jun 30, 2024 32.99 Mn
Mar 31, 2024 37.51 Mn
Dec 31, 2023 32.74 Mn
Sep 30, 2023 26.73 Mn
Jun 30, 2023 24.27 Mn
Mar 31, 2023 26.21 Mn
Dec 31, 2022 36.39 Mn
Sep 30, 2022 33.74 Mn
Jun 30, 2022 40.16 Mn
Mar 31, 2022 33.37 Mn
Dec 31, 2021 64.30 Mn
Sep 30, 2021 64.60 Mn
API Access

Scholar Rock Holding Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=SRRK&period=max&api_key=YOUR_API_KEY